Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

20.580
+0.3401.68%
Volume:2.06M
Turnover:42.52M
Market Cap:54.72B
PE:17.68
High:20.860
Open:20.500
Low:20.440
Close:20.240
52wk High:29.000
52wk Low:12.202
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:0.70
T/O Rate:0.38%
Dividend:0.36
Dividend Rate:1.74%
EPS(LYR):1.164
ROE:6.75%
ROA:1.32%
PB:1.02
PE(LYR):17.68
PS:1.23

Loading ...

Fosun Pharma Plans to Spin Off Vaccine Subsidiary for Hong Kong Listing, Reports 2024 Loss of 120 Million Yuan

Deep News
·
Yesterday

BUZZ-Shanghai Fosun Pharmaceutical climbs on vaccine unit's Hong Kong listing plan

Reuters
·
Yesterday

Fosun Pharmaceutical Unit Wins China Approval for Norepinephrine Injection

MT Newswires Live
·
Yesterday

Shanghai Fosun Pharmaceutical (02196) Announces Proposed Spin-Off of Fosun Adgenvax for Main Board Listing

Bulletin Express
·
Jan 22

Fosun Pharmaceutical Gets Nod for Colorectal Cancer Drug Clinical Trial

MT Newswires Live
·
Jan 21

InSilico Medicine Signs CNS Drug Deal With Hygtia Therapeutics; Shares Up 4%

MT Newswires Live
·
Jan 20

Fosun Pharma Unit Gets China Acceptance for Lung Cancer Drug Application

MT Newswires Live
·
Jan 08

Fosun Pharma's (600196.SH) Controlled Subsidiary Has Drug Registration Application Accepted

Stock News
·
Jan 08

Fosun Pharmaceutical-Backed Fund Completes Private Fund Filing

MT Newswires Live
·
Jan 06

Hong Kong Stock Announcement Highlights | Everest MED: Original Product Nefecon® Technology Protected by Valid Chinese Patent ZL200980127272.5

Stock News
·
Dec 30, 2025

Fosun Pharma's 1.4 Billion Yuan Bet on Discontinued Drug Draws Scrutiny Amid Efficacy Doubts

Deep News
·
Dec 23, 2025

Fosun Pharma's $1.4B Bet on Controversial Alzheimer's Drug: What's the Strategy?

Deep News
·
Dec 21, 2025

Fosun Pharma, ClavisBio Sign Five-Year Drug Collaboration Agreement; Shanghai Shares Rise 3%

MT Newswires Live
·
Dec 19, 2025

Fosun United Health Insurance Withdraws Announcement of 9 Medical Insurance Plans Covering Innovative Drugs

Deep News
·
Dec 18, 2025

FOSUN PHARMA (600196.SH) Subsidiary Signs Collaboration and Option Agreement with Clavis Bio

Stock News
·
Dec 18, 2025

Fosun Pharma Acquires Green Valley Pharma: A Ray of Hope for Alzheimer's Patients?

Deep News
·
Dec 16, 2025

HKEX Announcement Highlights | GUOXIA TECH to List Tomorrow with 1,890.73x Oversubscription; Big Three Airlines Report Over 10% YoY Passenger Traffic Growth in November

Stock News
·
Dec 15, 2025

FOSUN PHARMA (600196.SH): Supplemental New Drug Application for Serplulimab Injection Accepted

Stock News
·
Dec 12, 2025

FOSUN PHARMA (600196.SH): Ketoprofen Patch Receives Clinical Trial Approval

Stock News
·
Dec 12, 2025

Capital Securities Maintains "Buy" Rating on Fosun Pharma (02196) with Target Price of HK$26.5

Stock News
·
Dec 10, 2025